Frequently Asked Questions about Jazz Pharmaceuticals plc (JAZZ)

Name: Jazz Pharmaceuticals plc (JAZZ) Institutional Financial Dataset
Creator: Olyth
License: https://olyth.xyz

Question 1

What does Jazz Pharmaceuticals plc (JAZZ) do?

Accepted Answer

Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuro...

Question 2

Is Jazz Pharmaceuticals plc (JAZZ) a good stock to buy?

Accepted Answer

Olyth's institutional analysis of JAZZ reveals an Altman Z-Score of 1.53 and a Piotroski F-Score of 5/9. These metrics, combined with its 5-year revenue trend ($4.27B most recent), help investors decide if JAZZ fits their risk profile.

Question 3

What is the current P/E ratio for JAZZ?

Accepted Answer

As of the latest trading session, Jazz Pharmaceuticals plc (JAZZ) has a trailing P/E ratio of -33.23.

Question 4

Who is the CEO of Jazz Pharmaceuticals plc?

Accepted Answer

The current Chief Executive Officer of Jazz Pharmaceuticals plc is Renee D. Gala.

Question 5

What was JAZZ's revenue for the last 5 years?

Accepted Answer

According to its latest income statements, Jazz Pharmaceuticals plc reported annual revenues of $4.27B (2025), $4.07B (2024), $3.83B (2023), $3.66B (2022), $3.09B (2021) respectively.

Question 6

Does JAZZ pay a dividend?

Accepted Answer

Jazz Pharmaceuticals plc does not currently pay a dividend to its shareholders.

Question 7

How much debt and cash flow does JAZZ have?

Accepted Answer

In its latest reporting period, Jazz Pharmaceuticals plc generated $1.30B in Free Cash Flow against a total debt load of $5.42B.

Question 8

What is the Price-to-Book (P/B) ratio of Jazz Pharmaceuticals plc?

Accepted Answer

The Price-to-Book (P/B) ratio for Jazz Pharmaceuticals plc (JAZZ) is currently 2.74.

Question 9

What is the Price-to-Sales (P/S) ratio of JAZZ?

Accepted Answer

Based on trailing twelve-month data, Jazz Pharmaceuticals plc (JAZZ) trades at a Price-to-Sales (P/S) ratio of 2.80.

Question 10

What is Jazz Pharmaceuticals plc's Return on Equity (ROE)?

Accepted Answer

Jazz Pharmaceuticals plc (JAZZ) has a Return on Equity (ROE) of -8.82%, representing its profitability relative to shareholder equity.

Period	Operating CF	SBC	CapEx	Free CF	True FCF
2025-12	1.4B	291.1M	-58.8M	1.3B	1B
2024-12	1.4B	248M	-48.1M	1.3B	1.1B
2023-12	1.1B	226.8M	-24M	1.1B	841.2M
2022-12	1.3B	222M	-498.2M	773.8M	551.8M
2021-12	778.5M	189M	-45.5M	733M	544M

Period	Operating CF	SBC	CapEx	Free CF	True FCF
2025-12	1.4B	291.1M	-58.8M	1.3B	1B
2024-12	1.4B	248M	-48.1M	1.3B	1.1B
2023-12	1.1B	226.8M	-24M	1.1B	841.2M
2022-12	1.3B	222M	-498.2M	773.8M	551.8M
2021-12	778.5M	189M	-45.5M	733M	544M